Looking at Novo Nordisk and the fundamental I have a hard time thinking Novo would drop further at this point. However the technical setup indicates that if we don't hold the current level we could drop more than 15% from here.
- The head and shoulder is complete now we just need to see if we can get a follow through.
- Closing price Friday was below the 200 daily moving average.
The recent price drop is caused by a dissapoint in early trial results of their pill Monlunabant.
- The head and shoulder is complete now we just need to see if we can get a follow through.
- Closing price Friday was below the 200 daily moving average.
The recent price drop is caused by a dissapoint in early trial results of their pill Monlunabant.
Nota
This prediction is going in the right direction. I have not shorted, as this is in my opinion a quality stock. However I would look for a reaction at the 700 level for a possible by opportunity. Nota
We have observed a breakout accompanied by increased volume, which is an encouraging signal. Currently, the price is hovering around the 0.618 fibonacci retracement level, which is a profit-taking zone as it may indicate a potential reversal point. However, before confirming a clear rejection, I would like to see a lower level on Novo Nordisk.
Penafian
Maklumat dan penerbitan adalah tidak dimaksudkan untuk menjadi, dan tidak membentuk, nasihat untuk kewangan, pelaburan, perdagangan dan jenis-jenis lain atau cadangan yang dibekalkan atau disahkan oleh TradingView. Baca dengan lebih lanjut di Terma Penggunaan.
Penafian
Maklumat dan penerbitan adalah tidak dimaksudkan untuk menjadi, dan tidak membentuk, nasihat untuk kewangan, pelaburan, perdagangan dan jenis-jenis lain atau cadangan yang dibekalkan atau disahkan oleh TradingView. Baca dengan lebih lanjut di Terma Penggunaan.